Fundraising Fox
Millie Ray
InvestorFormer Partner at The Column Group
United States
Writes $100K – $5M checks · typically $1.5M
Find your path to Millie
Sign up to see every warm intro you have to Millie
- Paths you didn't know you had: your email and LinkedIn already hold routes to Millie. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Millie Ray is an MIT-trained PhD who rose from Associate to Partner since 2017 and leverages hands-on experience at Foghorn Therapeutics to found and incubate early-stage drug discovery biology companies.
Contact· self-published, not guessed
Invests in
BiotechHealthtech
Investments
Investor
Per curated public sources.
Frequently asked questions
- Who is Millie Ray?
- Millie Ray is an MIT-trained PhD who rose from Associate to Partner since 2017 and leverages hands-on experience at Foghorn Therapeutics to found and incubate early-stage drug discovery biology companies.
- What does Millie Ray invest in?
- Millie Ray invests in Biotech, Healthtech.
- What check size does Millie Ray write?
- Millie Ray typically writes checks of $100K – $5M.
- What companies has Millie Ray invested in?
- Investments tracked here include Casma Therapeutics, Hexagon Bio.
About this profile. Compiled from public sources — The Column Group's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights